JBF Capital, Inc.
Source: SEC Form 13F · as of Mar 2026JBF Capital, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $16.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$16.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 100,200 | $5.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 5,000 | $3.9M |
| LLYELI LILLY & Co | 3,000 | $2.8M |
| CNTACentessa Pharmaceuticals plc | 20,887 | $830K |
| APLSApellis Pharmaceuticals, Inc. | 20,532 | $826K |
| VMDViemed Healthcare Inc. | 43,578 | $401K |
| COYACoya Therapeutics, Inc. | 100,006 | $394K |
| GMOptec International, Inc. | 5,000 | $373K |
| ABUSArbutus Biopharma Corp | 80,281 | $361K |
| STIMNeuronetics Inc. | 233,166 | $338K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 900 | $244K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 10,285 | $100K |
| LSTALISATA THERAPEUTICS, INC. | 13,234 | $66K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.